1. Goadsby PJ.

Neurovascular headache and a midbrain vascular malformation: evidence

for a role of the brain stem in chronic migraine. Cephalalgia 2002; 22: 107-
2. Lassen Lh, Hadersley PA, Jacobson VB, Inversen HK, Perling B, Olesen J. CGRP may Play
a Causative role in migraine. Cephalalgia . 2002 ; 22 : 54-61
3. Milanov I, Bogdanova D. Trigemino-cervical reflex in patients with headache. Cephalalgia
2003;23:33-38
4. Lindsay DeVane C. Substance P: A Era, a New Role. Pharmacotherapy 2001; 21(9): 1061-
1069.
5. Piovesan EJ, Zukerman E, Kowacs PA, Werneck LC. COX-2 inhibitor for the treatment of
idiopathic stabbing headache secondary to cerebrovascular diseases. Cephalalgia
2002;22: 197-200.
6. von Peter S, Ting W, Serivani S, Korkin E, Okvat H, Gross M.et al. Survey on the
usecomplementary and alternative medicine among patients with headache
syndromes.Cephalalgia 2002;22:395-400.
7. Ho KH, Ong BKC. A community based study of headache diagnosis and prevalence in
Singapore. Cephalalgia 2002;23:6-13
8. Zanchin G, Maggioni F, Granella F, Rossi P, Falco L, Manzoni GC. Self-administexed pain-
relieving manoeuvres in primary headaches. Cephalalgia 2001 ;21 : 718-726.
9. Lauritzen M. Cortical spreading depression in migraine. Cephalalgia 2001;21: 757-760
10. Edvinsson L. Sensory nerves in man and their role in primary headaches. Cephalalgia
2001;21:761-764
11. Jensen TS. Recent advances in pain research: implications for chronic headache.
Cephalalgia 2001.21:765-769
12. Iversen HK. Human migraine models.Cephalalgia2001;21:781-785
13. Jensen R. Mechanisms of tension type headache. ;Cephalalgia 2001;21:786-789
14. Bolay H, Moskowitz MA. Mechanism of pain modulation in chronic syndromes. Neurology
2002;59(suppl):S2-S7
15. Lake III AE, Saper JR. Chronic Headache: New advances in treatment strategies.
Neurology 2002;59(Suppl 2):S8-S 13.
16. Bolay H, Reuter U, Dunn A, Chiarugi A, Boas D, Moskowitz M. Meningeal and central
trigeminovascular activation following cortical spreading depression. Cephalalgia 2001
;21: 526
17. Sjahrir H, Nasution D, Rambe H. Prevalensi nyeri kepala paroksismal pada mahasiswa
FK.USU Medan. dibacakan di Biennieal Meeting PNPNCh, Surabaya 1978.
18. Djali D, Sjahrir H. Pola penderita sefalgia pada poli neurologi FK.USU/RSHAM Medan.
Dibacakan padaPIT/Muker Perdossi, Malang 1998.
19. Evers S, Rahmann A, Vollmer-Hasse J, Hussteds IW. Treatment of headache with
botulinum toxin A- a review according to evidence-based medicine criteria. Cephalalgia
2002;22:699-710.
20. Gallagher RM. The Pain-Depression Conundrum: Bridging the Body and Mind. 21 st
Annual Scientific Meeting of the American pain Society. 2002
21. Headache Council Philippine Neurological Association: A Guide to Headache
Management in children and Adults. 1 st Edition. 2000
22. Gutman D, Nemeroff CB. The Neurobiology of Depression. Laboratory of
Neuropsychopharmacology, Department of Psychiatry, Emory University School of
Medicine, Atlanta, Georgia. Available from
http://www.medscape.com/viewrogram/2123 pnt CME Medscape 2002.
23. Hindmarch I. Beyond the monoamine hypothesis: mechanisms, molecules and
methods. Euro Psychiatry 2002; 17 Suppl 3: 294-299
24. Buzzi MG, Tassolrelli C, Nappi G. Peripheral and central activation of trigeminal pain
pathways in migraine: data from experimental animal models. Cephalalgia
2003;23(Suppl.l): 1-4
25. Cecchini AP, Sandrini, Fokin IV, Moglia A, Nappi G. Trigeminofacial reflexes in primary
headaches. Cephalalgia 2003;23(Suppl 1 ):33-41
26. Gallai V, Alberti A, Gallai B, Coppola F, Floridi A, Sarchielli P. Glutamate and nitic oxide
pathway in chronic daily headache: evidence ftorn cerebrospinal fluid.Cephalagia 2003
;23: 166-174
27. Landy SH. Migraine Headache and Allodynia: Early Use of Triptans to Improve
Outcome. Director, Wesley Headache Clinic, Memphis, Tennessee. Depart of Neurology
University ofTennessee.USA. Available from
http://www.medscape.com/viewrogram/464138 pnt CME Medscape Aug 2003
28. Bendtsen L. Central sensitization in tension type headache-possible pathophysiological
mechanisms. Cephalalgia 2000;20:486-508
29. Machelska H, Heppenstall PA, Stein C. Breaking the Pain Barrier. Nat Med2003;9(11):
1353-1354
30. Ondo WG, Vuong KD, Derman HS. Botulinum toxin A for chronic daily headache: a
randomized, placebo-controlled, parallel design study. Cephalalgia 2004;24:60-65
31. Silvestrini M, Bartolini M, Coccia M, Baruffaldi R, Taffi R, Provinciali I. Topiramate in
the treatment of chronic migraine. Cephalalgia 2003;23:820-824
32. Gutman D, Nemeroff CB. The Neurobiology of Depression. Laboratory of
Neuropsychopharmacology, Department of Psychiatry, Emory University School of
Medicine, Atlanta, Georgia. Available from
http://www.medscape.com/viewrogram/2123 pnt CME Medscape 2002.
33. © 2004 Digitized by USU digital library 15
34. DeNoon D.Migraine Linked to Brain Lesions, damage worse with more frequent, more
severe migraines.2004 WebMD.Inc. available from
http://content.health.msn.com/content/article/81/96863.htm
35. The International Classification of Headache Disorders,2nd Edition. Cephalalgia
2004;42 Supplement
36. Sjahrir H. Insidens jenis penyakit pasien yang berobat jalan dipraktek klinik saraf Klinik
spesialis Bunda tahun 2003
37. Kandel ER.Disorders of Mood:Depression, Mania, and Anxiety Disorders. In Principles
of Neural Science Ed. Kandel ER, Schwartz JR, Jessel MT. McGraw-Hill Health
Professions Division 2000; p 1209-1226.
38.